SCHEMBL14725757

SCHEMBL14725757

c1ccc2c(-c3cc4cc5c(cc(-c6csc7ccccc67)c6cc7c(cc65)sc5ccccc57)cc4c4cc5sc6ccccc6c5cc34)csc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.41
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ERN1 O75460 3/20 0.35
APP P05067 2/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2A6 P11509 3/20 0.33
C1S P09871 1/20 0.33
ALOX5 P09917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16472922 0.97 GPR3 (0.41) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL16472876 0.91 GPR3 (0.34) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL16472671 0.88 GPR3 (0.32) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL16472833 0.86 AHR (0.35) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL16472711 0.84 ALDH1A1 (0.32) MAPTALDH1A1HPGDPOLBTDP1
SCHEMBL16472940 0.84 AHR (0.35) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21180627 0.83 ALDH1A1 (0.34) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL21180639 0.82 ALDH1A1 (0.38) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL16472777 0.82 ALDH1A1 (0.30) ALDH1A1HPGD
SCHEMBL21180672 0.81 ALDH1A1 (0.35) GPR3MAPTALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 GPR3 3596/4885MAPT 717/4885ALDH1A1 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.